{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:48:10Z","timestamp":1784515690139,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","geriatric.theclinics.com","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.cger.2017.06.008","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T01:15:20Z","timestamp":1503105320000},"page":"563-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Lung Cancer in the Older Patient"],"prefix":"10.1016","volume":"33","author":[{"given":"Julie A.","family":"Barta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G.","family":"Zinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cger.2017.06.008_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.cger.2017.06.008_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"10.1016\/j.cger.2017.06.008_bib4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2015.65.9599","article-title":"Optimizing treatment risk and benefit for elderly patients with advanced non-small-cell lung cancer: the right treatment for the right patient","volume":"34","author":"Presley","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cllc.2015.02.006","article-title":"Treatment of elderly patients with non-small-cell lung cancer: results of an International expert panel meeting of the Italian Association of Thoracic Oncology","volume":"16","author":"Gridelli","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cger.2017.06.008_bib6","unstructured":"Ferlay J, Soerjomataram I, Ervik M, et\u00a0al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11(Internet) 2013. 2014. Available at: http:\/\/globocan.iarc.fr\/. Accessed November 20, 2016."},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1378\/chest.14-2500","article-title":"Components necessary for high-quality lung cancer screening: American College of chest physicians and American thoracic society policy statement","volume":"147","author":"Mazzone","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cger.2017.06.008_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa1301851","article-title":"Targeting of low-dose CT screening according to the risk of lung-cancer death","volume":"369","author":"Kovalchik","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.cger.2017.06.008_bib10","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1001\/jama.2016.6255","article-title":"Development and validation of risk models to select ever-smokers for CT lung cancer screening","volume":"315","author":"Katki","year":"2016","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.cger.2017.06.008_bib11","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1002\/cncr.28326","article-title":"The national lung screening trial: results stratified by demographics, smoking history, and lung cancer histology","volume":"119","author":"Pinsky","year":"2013","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cger.2017.06.008_bib12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/M14-1484","article-title":"National lung screening trial findings by age: Medicare-eligible versus under-65 population","volume":"161","author":"Pinsky","year":"2014","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.cger.2017.06.008_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/M14-2006","article-title":"Lung cancer screening and elderly adults: do we have sufficient evidence?","volume":"161","author":"Gould","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1378\/chest.12-0330","article-title":"Racial and ethnic differences in beliefs about lung cancer care","volume":"142","author":"Jonnalagadda","year":"2012","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.cger.2017.06.008_bib15","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/1055-9965.EPI-16-0354","article-title":"White-black differences in cancer incidence, stage at diagnosis, and survival among adults aged 85 years and older in the United States","volume":"25","author":"Krok-Schoen","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jamcollsurg.2012.09.019","article-title":"Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancer","volume":"216","author":"Revels","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cllc.2016.05.012","article-title":"Assessment of referral and chemotherapy treatment patterns for elderly patients with non-small-cell lung cancer","volume":"17","author":"Dawe","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10.1016\/j.cger.2017.06.008_bib18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.athoracsur.2012.10.079","article-title":"Effect of insurance status on the surgical treatment of early-stage non-small cell lung cancer","volume":"95","author":"Groth","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtho.2016.03.003","article-title":"Variations in receipt of curative-intent surgery for early-stage non-small cell lung cancer (NSCLC) by state","volume":"11","author":"Sineshaw","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"33","key":"10.1016\/j.cger.2017.06.008_bib20","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1200\/JCO.2016.67.7088","article-title":"Enrollment trends and disparity among patients with lung cancer in National clinical trials, 1990 to 2012","volume":"34","author":"Pang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cger.2017.06.008_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2014.03.050","article-title":"Age disparity in palliative radiation therapy among patients with advanced cancer","volume":"90","author":"Wong","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/cncr.25669","article-title":"Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer","volume":"117","author":"Hardy","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cllc.2016.05.007","article-title":"Relevance of a geriatric assessment for elderly patients with lung cancer-a systematic review","volume":"17","author":"Schulkes","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"13","key":"10.1016\/j.cger.2017.06.008_bib24","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.cger.2017.06.008_bib25","unstructured":"NCCN Guidelines: Older Adult Oncology. NCCN clinical practice guidelines in\u00a0oncology 2016, 2.2016. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed November 20, 2016."},{"issue":"24","key":"10.1016\/j.cger.2017.06.008_bib26","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International society of geriatric oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"25","key":"10.1016\/j.cger.2017.06.008_bib27","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.cger.2017.06.008_bib28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2015.63.5839","article-title":"Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study","volume":"34","author":"Corre","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1055\/s-0036-1592173","article-title":"Surgical treatment of early l stage lung cancer: what has changed and what will change in the future","volume":"37","author":"Sun","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib30","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.athoracsur.2011.06.082","article-title":"Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery","volume":"92","author":"Port","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jtcvs.2011.09.072","article-title":"Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population","volume":"143","author":"Rueth","year":"2012","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.athoracsur.2015.08.067","article-title":"Thirty-day mortality after lobectomy in elderly patients eligible for lung cancer screening","volume":"101","author":"Bravo Iniguez","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.cger.2017.06.008_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-U","article-title":"Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group","volume":"60","author":"Ginsberg","year":"1995","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.cger.2017.06.008_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/JTO.0000000000000083","article-title":"Comparative outcomes of elderly stage I lung cancer patients treated with segmentectomy via video-assisted thoracoscopic surgery versus open resection","volume":"9","author":"Smith","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cger.2017.06.008_bib35","unstructured":"NCCN Guidelines: Non-Small Cell Lung Cancer. NCCN clinical practice guidelines in oncology 2016, Version 3.2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed November 20, 2016."},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1513\/pats.201107-042ST","article-title":"International Association for the study of lung cancer\/American Thoracic Society\/European Respiratory Society: International multidisciplinary classification of lung adenocarcinoma: executive summary","volume":"8","author":"Travis","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jss.2015.08.045","article-title":"Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a surveillance, epidemiology, and end results database analysis","volume":"200","author":"Razi","year":"2016","journal-title":"J\u00a0Surg Res"},{"issue":"12","key":"10.1016\/j.cger.2017.06.008_bib38","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamasurg.2014.556","article-title":"Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly","volume":"149","author":"Shirvani","year":"2014","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.cger.2017.06.008_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5761\/atcs.oa.15-00365","article-title":"Factors determining the choice of surgical procedure in elderly patients with non-small cell lung cancer","volume":"22","author":"Okamoto","year":"2016","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"14","key":"10.1016\/j.cger.2017.06.008_bib40","doi-asserted-by":"crossref","first-page":"19081","DOI":"10.18632\/oncotarget.7704","article-title":"Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.cger.2017.06.008_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00595-016-1314-8","article-title":"Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?","volume":"46","author":"Fiorelli","year":"2016","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib42","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2012.07.2354","article-title":"Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly","volume":"84","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cger.2017.06.008_bib43","unstructured":"Comparison of different types of surgery in treating patients with stage IA non-small cell lung cancer. 2016. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00499330. Accessed November 20, 2016."},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib44","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.cger.2017.06.008_bib45","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1002\/cncr.29640","article-title":"Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: a National cancer data base analysis","volume":"121","author":"Nanda","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cger.2017.06.008_bib46","doi-asserted-by":"crossref","first-page":"i3570","DOI":"10.1136\/bmj.i3570","article-title":"Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis","volume":"354","author":"Paul","year":"2016","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.cger.2017.06.008_bib47","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/cncr.29507","article-title":"Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial","volume":"121","author":"Dupuy","year":"2015","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.cger.2017.06.008_bib48","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group","volume":"26","author":"Pignon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cger.2017.06.008_bib49","doi-asserted-by":"crossref","first-page":"d4013","DOI":"10.1136\/bmj.d4013","article-title":"Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study","volume":"343","author":"Wisnivesky","year":"2011","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.cger.2017.06.008_bib50","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1002\/cncr.29360","article-title":"Effect of age on the efficacy of adjuvant chemotherapy for resected non\u2013small cell lung cancer","volume":"121","author":"Ganti","year":"2015","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.cger.2017.06.008_bib51","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2011.39.3330","article-title":"Adjuvant chemotherapy for non\u2013small-cell lung cancer in the elderly: a population-based study in Ontario, Canada","volume":"30","author":"Cuffe","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib52","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(12)70139-0","article-title":"Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)","volume":"13","author":"Atagi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib53","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/annonc\/mdr565","volume":"23","author":"Jalal","year":"2011","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/JTO.0b013e31820eed00","article-title":"Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer","volume":"6","author":"Davidoff","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cger.2017.06.008_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.lungcan.2016.07.016","article-title":"Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis","volume":"99","author":"Dawe","year":"2016","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2014.07.014","article-title":"Cisplatin vs. carboplatin-based chemoradiotherapy in patients\u00a0>65 years of age with stage III non-small cell lung cancer","volume":"112","author":"Ezer","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib57","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.lungcan.2013.06.011","article-title":"Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer","volume":"82","author":"Sigel","year":"2013","journal-title":"Lung Cancer"},{"issue":"9796","key":"10.1016\/j.cger.2017.06.008_bib58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","article-title":"Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial","volume":"378","author":"Quoix","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cger.2017.06.008_bib59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/JCO.2014.55.8627","article-title":"Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3\u00a0weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803\/WJOG4307L","volume":"33","author":"Abe","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.cger.2017.06.008_bib60","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/cncr.28022","article-title":"Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer","volume":"119","author":"Zhu","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/annonc\/mds461","article-title":"Safety and efficacy of weekly nab(R)-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer","volume":"24","author":"Socinski","year":"2013","journal-title":"Ann Oncol"},{"issue":"10S","key":"10.1016\/j.cger.2017.06.008_bib62","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.jtho.2016.08.070","article-title":"P1.48: nab-Paclitaxel\u00a0+ Carboplatin in advanced non-small cell lung cancer: outcomes in elderly patients with squamous histology: track: advanced NSCLC","volume":"11","author":"Gridelli","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cllc.2013.11.011","article-title":"Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non\u2013small-cell lung cancer","volume":"15","author":"Gridelli","year":"2014","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/JTO.0000000000000207","article-title":"Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study","volume":"9","author":"Gridelli","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"15","key":"10.1016\/j.cger.2017.06.008_bib65","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.2012.454","article-title":"Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer","volume":"307","author":"Zhu","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cger.2017.06.008_bib66","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/COC.0000000000000163","article-title":"Isolating the role of Bevacizumab in elderly patients with previously untreated nonsquamous non-small cell lung cancer: secondary analyses of the ECOG 4599 and pointbreak trials","volume":"39","author":"Langer","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.21037\/tlcr.2016.03.03","article-title":"Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that\u2019s the question","volume":"5","author":"Gridelli","year":"2016","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.cger.2017.06.008_bib68","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/cncr.21034","article-title":"Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly","volume":"103","author":"Schild","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cger.2017.06.008_bib69","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/1097-0142(20001101)89:9<1953::AID-CNCR11>3.3.CO;2-Y","article-title":"Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma","volume":"89","author":"Yuen","year":"2000","journal-title":"Cancer"},{"issue":"36","key":"10.1016\/j.cger.2017.06.008_bib70","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1200\/JCO.2015.62.4270","article-title":"Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer","volume":"33","author":"Corso","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.cger.2017.06.008_bib71","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoncol.2015.4482","article-title":"Association between younger age and targetable genomic alterations and prognosis in non\u2013small-cell lung cancer","volume":"2","author":"Sacher","year":"2016","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2015.63.4600","article-title":"MET Exon 14 mutations in non\u2013small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met overexpression","volume":"34","author":"Awad","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"10026","key":"10.1016\/j.cger.2017.06.008_bib73","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet"},{"issue":"10066","key":"10.1016\/j.cger.2017.06.008_bib74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"Yang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.cger.2017.06.008_bib76","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO.2007.15.2280","article-title":"Erlotinib for advanced non\u2013small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada clinical trials group study BR.21","volume":"26","author":"Wheatley-Price","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.cger.2017.06.008_bib77","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.jtho.2016.08.055","article-title":"P1.33: afatinib versus chemotherapy for EGFR mutation-positive NSCLC patients aged \u2265 65 years: subgroup analysis of LUX-lung 3\/6: track: advanced NSCLC","volume":"11","author":"Fein","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"26","key":"10.1016\/j.cger.2017.06.008_bib78","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2007.15.0672","article-title":"Gefitinib versus vinorelbine in chemotherapy-na\u00efve elderly patients with advanced non\u2013small-cell lung cancer (INVITE): a randomized, phase II study","volume":"26","author":"Crin\u00f2","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.cger.2017.06.008_bib79","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/JTO.0b013e318260de8b","article-title":"First-line gefitinib in patients aged 75 or older with advanced non\u2013small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study","volume":"7","author":"Maemondo","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10","key":"10.1016\/j.cger.2017.06.008_bib80","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(12)70344-3","article-title":"Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study","volume":"13","author":"Camidge","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.cger.2017.06.008_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.cger.2017.06.008_bib82","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10027","key":"10.1016\/j.cger.2017.06.008_bib83","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"issue":"10066","key":"10.1016\/j.cger.2017.06.008_bib84","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.cger.2017.06.008_bib85","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cger.2017.06.008_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1470-2045(16)30098-5","article-title":"Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1\/2 trial","volume":"17","author":"Antonia","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069017300575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069017300575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T07:53:48Z","timestamp":1535442828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069017300575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0749069017300575"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2017.06.008","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung Cancer in the Older Patient","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2017.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}